CTRI/2018/03/012718
Not yet recruiting
Phase 2
An Open Label,Prospective,Phase II,Clinical study to Evaluate Efficacy and safety of syp.Rubyclin in the Eczema.
Aushadhi Bhavan0 sites0 target enrollmentStarted: TBDLast updated:
Overview
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
- Aushadhi Bhavan
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •subjects with inflammation redness itching burning in eczema
Exclusion Criteria
- •Subjects with Diabetes Mellitus Type I and uncontrolled Diabetes Mellitus Type II.Known subjects of abnormal thyroid function.Known cases of Severe/Chronic Hepatic or Renal disease.Known subject of any active malignancy.Subjects giving history of significant cardiovascular event \< 12 weeks prior to randomization.Subjects ECG demonstrating any signs of uncontrolled arrhythmia / acute ischemia.Lesions of large surface area.Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.Subjects using any other investigational drug within 3 days prior to recruitment.Known hypersensitivity to any of the ingredients used in study drug.Pregnant and Lactating femalesSubjects currently participating in any other Clinical studyAny other medical or surgical condition considered unsuitable for subject participation in the study as per Investigator judgment.Subject having H/O keliod formation following skin injury,severe dermatitis requiring systemic corticosteroids
Investigators
Similar Trials
Not yet recruiting
Phase 2
To find out effect of syp.JTV in patients suffering from cough.Health Condition 1: null- BronchitiscoughDysnoeasore throatNasal congestionCTRI/2018/03/012516Aushadhi Bhavan
Not yet recruiting
Phase 2
Efficacy and Safety of Barphani Ointment in patients suffering from Chronic plaque PsoriasisHealth Condition 1: L00-L99- Diseases of the skin and subcutaneous tissueCTRI/2019/08/020504Ayurved Sanshodhan Vibhag
Not yet recruiting
Phase 2
Effectivity of Barphani Ointment in patients suffering from Eczema.Health Condition 1: - Health Condition 2: L239- Allergic contact dermatitis, unspecified causeCTRI/2019/08/020618Ayurved Sanshodhan Vibhag
Completed
Phase 2
To evaluate the safety and efficacy of Arnophyte Cream in subjects with HerpesHealth Condition 1: null- Early signs & symptoms of recurrent HSV-2Health Condition 2: B008- Other forms of herpesviral infectionsCTRI/2018/01/011171Piramal Enterprises Limited40
Completed
Phase 2
To assess the safety and effectiveness of DPOR/JR2007 Tablets in Osteoarthritis of the Knee.CTRI/2017/07/009054Deltas Pharma45